Schizophrenia.com
Risk factors for psychotic relapse after dose reduction or discontinuation of antipsychotics in patients with chronic schizophrenia. A systematic review and meta-analysis
News
firemonkey
March 2, 2020, 12:33pm
1
1 Like
Related topics
Topic
Replies
Views
Activity
Lower-Dose Schizophrenia Medication Increases Risk of Relapse or Discontinuation
News
2
229
August 10, 2021
Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials
News
5
404
May 28, 2021
Clinical Characteristics of Patients With Schizophrenia Who Successfully Discontinued Antipsychotics: A Literature Review
News
4
519
October 12, 2018
Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial
News
0
327
February 18, 2020
Predicting psychotic relapse following randomised discontinuation of paliperidone in individuals with schizophrenia or schizoaffective disorder: an individual participant data analysis
News
0
214
February 16, 2023